NCT06097533View on ClinicalTrials.gov

Improvement of Quality of Life by Cannabinoids in Oncologic Patients

PHASE2RecruitingINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

April 8, 2024

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
Medical OncologyPalliative CareQuality of LifeCannabinoids
Interventions
DRUG

Cannabisextrakt Avextra 10/10 Lösung

medical cannabinoids

Trial Locations (4)

20246

RECRUITING

Hubertus Wald Tumorzentrum Universitäres Cancer Center Hamburg (UCCH), Hamburg

24105

RECRUITING

University Hospital Schleswig-Holstein, Kiel

RECRUITING

University Hospital Schleswig-Holstein, Kiel

Unknown

RECRUITING

University Hospital Schleswig-Holstein, Lübeck

Sponsors

Collaborators (1)

Avextra Pharma GmbH
All Listed Sponsors
collaborator

Avextra Pharma GmbH

UNKNOWN

collaborator

SocraMetrics GmbH

INDUSTRY

lead

University Hospital Schleswig-Holstein

OTHER

NCT06097533 - Improvement of Quality of Life by Cannabinoids in Oncologic Patients | Biotech Hunter | Biotech Hunter